Research output per year
Research output per year
Personal profile
Biographical details
2015-2019. PhD in Neurovascular Pharmacology. Div. Vascular Pharmacology, Dept. Internal Medicine, Erasmus University Medical Centre. Rotterdam, the Netherlands.
2013-2015. MSc in Neuropharmacology and Experimental Therapeutics. Dept. Pharmacobiology. Center for Research and Advanced Studies of the National Polytechnic Institute. Mexico City, Mexico.
2011-2013. Intern, Pain and Epilepsy Group. UNAM Institute of Neurobiology, Queretaro, Mexico.
2007-2013. BSc in Chemical-Pharmaceutical Biology. Chemistry Faculty. Autonomous University of Queretaro. Queretaro, Mexico.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Junior Editorial Board Member, The Journal of Headache and Pain
Fingerprint
Dive into the research topics where Amada Eloisa Rubio Beltran is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Blocking CGRP in migraine patients – a review of pros and cons
On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS), 1 Dec 2017, In: Journal of Headache and Pain. 18, 1, 96.Research output: Contribution to journal › Review article › peer-review
Open Access207 Citations (Scopus) -
Long COVID headache
Tana, C., Bentivegna, E., Cho, S-J., Harriott, A. M., García-Azorín, D., Labastida-Ramirez, A., Ornello, R., Raffaelli, B., Beltrán, E. R., Ruscheweyh, R. & Martelletti, P., 1 Aug 2022, In: Journal of Headache and Pain. 23, 1, p. 93 93.Research output: Contribution to journal › Review article › peer-review
Open Access83 Citations (Scopus) -
Understanding CGRP and cardiovascular risk
Rubio-Beltrán, E. & van den Brink, A. M., 2019, Handbook of Experimental Pharmacology. Springer New York LLC, p. 131-140 10 p. (Handbook of Experimental Pharmacology; vol. 255).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
14 Citations (Scopus) -
PACAP38 and PAC1 receptor blockade: a new target for headache?
European Headache Federation School of Advanced Studies (EHF-SAS), 7 Aug 2018, In: The journal of headache and pain. 19, 1, p. 64 1 p., 64.Research output: Contribution to journal › Review article › peer-review
Open Access59 Citations (Scopus) -
Gender aspects of CGRP in migraine
Labastida-Ramírez, A., Rubio-Beltrán, E., Villalón, C. M. & MaassenVanDenBrink, A., 1 Mar 2019, In: Cephalalgia. 39, 3, p. 435-444 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access91 Citations (Scopus)
Prizes
-
Early Career Research Award for Postdoctoral Researchers
Rubio Beltran, Amada Eloisa (Recipient), 2023
Prize: Prize (including medals and awards)
-
Migraine Trust Postdoctoral Fellowship
Rubio Beltran, Amada Eloisa (Recipient), 2023
Prize: Fellowship awarded competitively
-